References
-
1) Maternal 25-Hydroxyvitamin D Deficiency Promoted Metabolic Syndrome and Downregulated Nrf2/CBR1 Pathway in Offspring.
Product: CBR1 Antibody (#DF3893)Year: 2020Journal: FRONT PHARMACOLImpactFactor: 5.6DOI: 10.3389/fphar.2020.00097PMID: 32184720 -
2) Effect of CLIP3 Upregulation on Astrocyte Proliferation and Subsequent Glial Scar Formation in the Rat Spinal Cord via STAT3 Pathway After Injury.
Product: CLIP3 Antibody (#DF3878)Year: 2017Journal: J MOL NEUROSCIImpactFactor: 2.8DOI: 10.1007/s12031-017-0998-6PMID: 29218499 -
3) Curcumol enhances the sensitivity of doxorubicin in triple-negative breast cancer via regulating the miR-181b-2-3p-ABCC3 axis.
Product: ABCC3 Antibody (#DF3874)Year: 2020Journal: BIOCHEM PHARMACOLImpactFactor: 5.3DOI: 10.1016/j.bcp.2020.113795PMID: 31926937 -
4) Gut microbiota-mediated C-sulfonate metabolism impairs the bioavailability and anti-cholestatic efficacy of andrographolide.
Product: ABCC2 Ab (#DF3873)Year: 2024Journal: GUT MICROBESImpactFactor: 12.2DOI: 10.1080/19490976.2024.2387402 -
5) RPF2 mediates the CARM1‑MYCN axis to promote chemotherapy resistance in colorectal cancer cells.
Product: ABCC2 Antibody (#DF3873)Year: 2024Journal: Oncol RepImpactFactor: 3.8DOI: 10.3892/or.2023.8670PMID: 37997821 -
6) 4′-OH as the Action Site of Lipids and MRP1 for Enhanced Transdermal Delivery of Flavonoids.
Product: ABCC2 Antibody (#DF3873)Year: 2023Journal: ACS Appl Mater InterfacesImpactFactor: 8.3DOI: 10.1021/acsami.2c18086PMID: 36913526 -
7) QiShenYiQi pills, a Chinese patent medicine, increase bioavailability of atorvastatin by inhibiting Mrp2 expression in rats.
Product: ABCC2 Antibody (#DF3873)Year: 2022Journal: PHARM BIOLImpactFactor: 3.9DOI: 10.1080/13880209.2021.2021949PMID: 35001796 -
8) Dolomiaea souliei ethyl acetate extract protected against α-naphthylisothiocyanate-induced acute intrahepatic cholestasis through regulation of farnesoid x receptor-mediated bile acid metabolism.
Product: ABCC2 Antibody (#DF3873)Year: 2021Journal: PHYTOMEDICINEImpactFactor: 6.7DOI: 10.1016/j.phymed.2021.153588PMID: 34091148 -
9) Advanced oxidation protein products upregulate efflux transporter expression and activity through activation of the Nrf-2-mediated signaling pathway in vitro and in vivo.
Product: ABCC2 Antibody (#DF3873)Year: 2020Journal: EUR J PHARM SCIImpactFactor: 4.3DOI: 10.1016/j.ejps.2020.105342PMID: 32315774 -
10) Insulin Receptor Substrate p53 Ameliorates High-Glucose-Induced Activation of NF-κB and Impaired Mobility of HUVECs.
Product: BAIAP2L1 Antibody (#DF3853)Year: 2021Journal: BIOMED RES INTImpactFactor: 2.6DOI: 10.1155/2021/3210586PMID: 33506012 -
11) Type 2 diabetes mellitus facilitates endometrial hyperplasia progression by activating the proliferative function of mucin O-glycosylating enzyme GALNT2.
Product: BRP44L Antibody (#DF3852)Year: 2020Journal: BIOMED PHARMACOTHERImpactFactor: 6.9DOI: 10.1016/j.biopha.2020.110764PMID: 33152927 -
12) Non-Esterified Fatty Acid-Induced Apoptosis in Bovine Granulosa Cells via ROS-Activated PI3K/AKT/FoxO1 Pathway.
Product: BST2 Antibody (#DF3846)Year: 2023Journal: Antioxidants (Basel)ImpactFactor: 7DOI: 10.3390/antiox12020434PMID: 36829992 -
13) Proteomic analyses reveal higher levels of neutrophil activation in men than in women with systemic lupus erythematosus.
Product: BST2 Antibody (#DF3846)Year: 2022Journal: FRONT IMMUNOLImpactFactor: 5.7DOI: 10.3389/fimmu.2022.911997PMID: 35799787 -
14) Over-Expression and Prognostic Significance of FATP5, as a New Biomarker, in Colorectal Carcinoma.
Product: SLC27A5 Antibody (#DF3845)Year: 2022Journal: FRONT MOL BIOSCIImpactFactor: 5DOI: 10.3389/fmolb.2021.770624PMID: 35155561 -
15) SARS-CoV-2 membrane protein causes the mitochondrial apoptosis and pulmonary edema via targeting BOK.
Product: BOK Antibody (#DF3829)Year: 2022Journal: Cell Death DifferImpactFactor: 13.7DOI: 10.1038/s41418-022-00928-xPMID: 35022571